22 February 2018
News and Views
Links and Services
December's publication of the American Journal of Gastroenterology compares a once-daily with conventional dosing schedule of mesalamine in preventing relapse of quiescent ulcerative colitis.
Maintenance therapy with 5-aminosalicylates is recommended in patients with quiescent ulcerative
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors